Ectopic fat deposition and global cardiometabolic risk: new paradigm in cardiovascular medicine.

The obesity epidemic is a global public health concern that increases the likelihood of morbidity and mortality of metabolic and cardiovascular disease (CVD) and threatens to reduce life expectancy around the world. The concept of the metabolic syndrome (MetS) takes into account that visceral fat plays an essential role in the development of metabolic and cardiovascular diseases. However, MetS cannot be used to assess global CVD risk but is at best one more modifiable CVD risk factor. Thus, global cardiometabolic risk (the global risk of cardiovascular disease resulting from traditional risk factors combined with the additional contribution of the metabolic syndrome and/or insulin resistance) should be considered individually. There is solid evidence supporting the notion that excess abdominal fat is predictive of insulin resistance and the presence of related metabolic abnormalities currently referred to as MetS. Despite the fact that abdominal obesity is a highly prevalent feature of MetS, the mechanisms by which abdominal obesity is causally related to MetS are not fully elucidated. Besides visceral fat accumulation, ectopic lipid deposition, especially in liver and skeletal muscle, has been implicated in the pathophysiology of diabetes, insulin resistance and obesity-related disorders. Also, ectopic fat deposition could be deteriorated in the heart components such as (1) circulatory and locally recruited fat, (2) intra- and extra-myocellular fat, (3) perivascular fat, and (4) pericardial fat. In this review, the contribution of ectopic lipid deposition to global cardiometabolic risk is reviewed and also discussed are potential underlying mechanisms including adipocytokine, insulin resistance and lipotoxicity.

[1]  平良 伸一郎 Lipid deposition in various sites of skeletal muscle and liver shows positive correlation with visceral fat accumulation in middle-aged Japanese male patients with metabolic syndrome , 2013 .

[2]  中西 弘毅 Peri-atrial epicardial adipose tissue is associated with new-onset nonvalvular atrial fibrillation , 2013 .

[3]  G. Lopaschuk,et al.  Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease. , 2012, American journal of physiology. Endocrinology and metabolism.

[4]  T. Wakatsuki,et al.  Gender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: A 3-dimensional cardiac computed tomography imaging study in Japanese subjects , 2012, Cardiovascular Diabetology.

[5]  Jean-PierreDesprés Body Fat Distribution and Risk of Cardiovascular Disease , 2012 .

[6]  J. Després,et al.  Body Fat Distribution and Risk of Cardiovascular Disease: An Update , 2012, Circulation.

[7]  M. Szklo,et al.  The Multi-Ethnic Study of Atherosclerosis (MESA) , 2012 .

[8]  H. Sacks,et al.  Human epicardial fat: what is new and what is missing? , 2011, Clinical and experimental pharmacology & physiology.

[9]  John Spertus,et al.  AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. , 2011, Circulation.

[10]  G. Iacobellis,et al.  Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features , 2011, Trends in Endocrinology & Metabolism.

[11]  Tetsuya Kitagawa,et al.  Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. , 2011, Journal of the American College of Cardiology.

[12]  T. Wadden,et al.  Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes , 2011, Diabetes Care.

[13]  R. Ross,et al.  Cardiometabolic Risk in Canada: a Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group Introduction to the Concepts of Cardiometabolic Risk, Metabolic Syndrome, and Risk Stratification: Finding the Forest among the Trees E2 , 2022 .

[14]  G. Bray,et al.  The Relationship of Waist Circumference and BMI to Visceral, Subcutaneous, and Total Body Fat: Sex and Race Differences , 2011, Obesity.

[15]  D. Wilber,et al.  Pericardial fat is independently associated with human atrial fibrillation. , 2010, Journal of the American College of Cardiology.

[16]  S. Shioda,et al.  Endovascular Injury Induces Rapid Phenotypic Changes in Perivascular Adipose Tissue , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[17]  Udo Hoffmann,et al.  Pericardial Fat Is Associated With Prevalent Atrial Fibrillation: The Framingham Heart Study , 2010, Circulation. Arrhythmia and electrophysiology.

[18]  Moyses Szklo,et al.  The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2009, The American journal of clinical nutrition.

[19]  M. Shimabukuro Cardiac adiposity and global cardiometabolic risk: new concept and clinical implication. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[20]  Philippe Pibarot,et al.  Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[21]  D. Roden,et al.  Metabolic Syndrome and Risk of Development of Atrial Fibrillation: The Niigata Preventive Medicine Study , 2008, Circulation.

[22]  Udo Hoffmann,et al.  Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample: The Framingham Heart Study , 2008, Circulation.

[23]  A. Selwyn Weight reduction and cardiovascular and metabolic disease prevention: clinical trial update. , 2007, The American journal of cardiology.

[24]  L. Orci,et al.  Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. , 2007, Circulation research.

[25]  J. Després,et al.  Obesity and Metabolic Syndrome Are Independent Risk Factors for Atrial Fibrillation After Coronary Artery Bypass Graft Surgery , 2007, Circulation.

[26]  Mahbubur Rahman,et al.  Impact of Metabolic Syndrome on the Development of Cardiovascular Disease in a General Japanese Population: The Hisayama Study , 2007, Stroke.

[27]  X. Jouven,et al.  Contribution of the metabolic syndrome to sudden death risk in asymptomatic men: the Paris Prospective Study I. , 2007, European heart journal.

[28]  G. Bray,et al.  Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes , 2007, Diabetes Care.

[29]  A. Moss,et al.  Obesity As a Risk Factor for Sustained Ventricular Tachyarrhythmias in MADIT II Patients , 2007, Journal of cardiovascular electrophysiology.

[30]  A. Bradbury,et al.  Obesity and thrombosis. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[31]  F. Schick,et al.  High Visceral Fat Mass and High Liver Fat Are Associated with Resistance to Lifestyle Intervention , 2007, Obesity.

[32]  S. Grundy Controversy in Clinical Endocrinology Metabolic Syndrome: a Multiplex Cardiovascular Risk Factor Mets as a Multiplex Cardiovascular Risk Factor , 2022 .

[33]  J. Obata,et al.  High prevalence of paroxysmal atrial fibrillation and/or atrial flutter in metabolic syndrome. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[34]  Parvez Hossain,et al.  Obesity and diabetes in the developing world--a growing challenge. , 2007, The New England journal of medicine.

[35]  R. Gropler,et al.  Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. , 2006, European heart journal.

[36]  N. Takasu,et al.  Vascular lipotoxicity: endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats. , 2007, Endocrinology.

[37]  S. Kahn,et al.  Review: The role of insulin resistance in nonalcoholic fatty liver disease. , 2006, The Journal of clinical endocrinology and metabolism.

[38]  K. Node,et al.  Vascular failure: a new clinical entity for vascular disease , 2006, Journal of hypertension.

[39]  P. Iozzo,et al.  Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. , 2006, The Journal of clinical endocrinology and metabolism.

[40]  S. Svacina,et al.  Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. , 2006, The Journal of clinical endocrinology and metabolism.

[41]  T. Funahashi,et al.  Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[42]  V. Davutoglu,et al.  Uncomplicated Metabolic Syndrome Is Associated with Prolonged Electrocardiographic QTc Interval and QTc Dispersion , 2006, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[43]  A. Folsom,et al.  Risk Factors for Ischemic Stroke Subtypes: The Atherosclerosis Risk in Communities Study , 2006, Stroke.

[44]  Kohjiro Ueki,et al.  Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. , 2006, The Journal of clinical investigation.

[45]  E. Ingelsson,et al.  Metabolic syndrome and risk for heart failure in middle-aged men , 2006, Heart.

[46]  Ajay M Shah,et al.  Oxidative stress and redox signalling in cardiac hypertrophy and heart failure , 2006, Heart.

[47]  M. Zou,et al.  Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. , 2006, The Journal of clinical investigation.

[48]  E. Ingelsson,et al.  Novel metabolic risk factors for heart failure. , 2005, Journal of the American College of Cardiology.

[49]  G. Targher,et al.  Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. , 2005, Diabetes.

[50]  P. Meda,et al.  Production of Chemokines by Perivascular Adipose Tissue: A Role in the Pathogenesis of Atherosclerosis? , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[51]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[52]  R. Kahn,et al.  The metabolic syndrome: time for a critical appraisal , 2005, Diabetologia.

[53]  Ildikó Kriszbacher,et al.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, New England Journal of Medicine.

[54]  J. McGavock,et al.  Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. , 2005, American journal of physiology. Endocrinology and metabolism.

[55]  C. Stehouwer,et al.  “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease , 2005, The Lancet.

[56]  S. Olshansky,et al.  A potential decline in life expectancy in the United States in the 21st century. , 2005, The New England journal of medicine.

[57]  R. Brandes,et al.  Vascular NADPH oxidases: molecular mechanisms of activation. , 2005, Cardiovascular research.

[58]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[59]  Steven Hawken,et al.  Preventive cardiologyAbstractsEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study , 2004 .

[60]  Fritz Schick,et al.  Intrahepatic lipids are predicted by visceral adipose tissue mass in healthy subjects. , 2004, Diabetes care.

[61]  D. Harrison,et al.  Redox Mechanisms in Blood Vessels , 2004 .

[62]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[63]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[64]  G. Metzger,et al.  Myocardial triglycerides and systolic function in humans: In vivo evaluation by localized proton spectroscopy and cardiac imaging , 2003, Magnetic resonance in medicine.

[65]  Douglas W Mahoney,et al.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.

[66]  R. Unger,et al.  Lipotoxic diseases. , 2002, Annual review of medicine.

[67]  B. Goodpaster,et al.  Muscle triglyceride and insulin resistance. , 2002, Annual review of nutrition.

[68]  J. Marrugat,et al.  Relationship of obesity distribution and peripheral arterial occlusive disease in elderly men , 2000, International Journal of Obesity.

[69]  M. Samama,et al.  An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. , 2000, Archives of internal medicine.

[70]  S. O’Rahilly,et al.  The perils of portliness: causes and consequences of visceral adiposity. , 2000, Diabetes.

[71]  L. Orci,et al.  Lipotoxic heart disease in obese rats: implications for human obesity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[72]  T. Funahashi,et al.  Molecular Mechanism of Metabolic Syndrome X: Contribution of Adipocytokines · Adipocyte‐derived Bioactive Substances , 1999, Annals of the New York Academy of Sciences.

[73]  L. Wilhelmsen,et al.  Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: "the study of men born in 1913". , 1999, Archives of internal medicine.

[74]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[75]  L. DiPietro,et al.  Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study , 1999, Diabetologia.

[76]  R. Unger,et al.  Fatty acid-induced β cell apoptosis: A link between obesity and diabetes , 1998 .

[77]  D. Harrison,et al.  Cellular and molecular mechanisms of endothelial cell dysfunction. , 1997, The Journal of clinical investigation.

[78]  R. Unger,et al.  Role of nitric oxide in obesity-induced beta cell disease. , 1997, The Journal of clinical investigation.

[79]  C. Newgard,et al.  Direct antidiabetic effect of leptin through triglyceride depletion of tissues. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[80]  G. Lowe,et al.  The relationship between cigarette smoking and cardiovascular risk factors in peripheral arterial disease compared with ischaemic heart disease. The Edinburgh Artery Study. , 1995, European heart journal.

[81]  P. Elwood,et al.  Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. , 1994, British heart journal.

[82]  小谷 一晃 Sexual dimorphism of age-related changes in whole-body fat distribution in the obese , 1994 .

[83]  M J Shipley,et al.  Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. , 1990, Circulation.